Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Biol Chem. 2016 Dec 1;397(12):1265–1276. doi: 10.1515/hsz-2016-0177

Table 1.

Association between clinical characteristics of advanced ovarian cancer patients (FIGO III/IV) and tumor biological factors.

Clinical parameters No. of patients KLK6a Low/high KLK8a Low/high KLK6+KLK8b Low/high

Total no. of patients 100 49/50 50/50 34/65

Age P = 0.919 P = 0.841 P = 0.942
 ≤ 60 years 49 24/25 25/24 17/32
 > 60 years 51 25/25 25/26 17/33

Residual tumor mass P = 0.230 P = 0.359 P = 0.062
 0 mm 45 25/20 25/20 20/25
 > 0 mm 54 23/30 25/29 14/39

Ascitic fluid volume P = 0.875 P = 0.551 P = 0.264
 ≤ 500 ml 46 25/21 26/20 20/26
 > 500 ml 38 20/18 19/19 12/26
a

Chi-square test (cutoff point = median)

b

High KLK6+KLK8: KLK6 and/or KLK8 above median; low KLK6+KLK8: KLK6 and KLK8 both below median